Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Functional Evaluation of CIC Missense Mutations Identified in Neuropsychiatric Disorders
Child Neurology and Developmental Neurology
S8 - State-of-the-art Diagnostics in Child Neurology (4:06 PM-4:18 PM)
004

Our lab discovered heterozygous de-novo truncating variants in the transcriptional repressor CIC lead to CIC Haploinsufficiency Syndrome (CHS), a neurodevelopmental disorder characterized by intellectual disability, ADHD, autism, and seizures. To understand how loss of CIC leads to these phenotypes, we generated both germline and conditional loss-of-function (LOF) mouse models. Cicnull/null mice die perinatally, however, conditional LOF models ablating Cic in different brain regions recapitulate CHS phenotypes, suggesting that mice are an ideal system to study CIC biology. We recently identified individuals with CHS phenotypes and denovo CIC missense variants of unknown significance.  Additionally, rare de-novo CIC missense variants have been described in schizophrenia cohorts. We propose these missense variants alter CIC function along a spectrum, with more severe variants leading to CHS and milder variants leading to schizophrenia.

Evaluate the functional consequences of CIC missense variants seen in individuals with neuropsychiatric disease.

We used CRISPR-Cas9 to generate six knock-in (KI) mouse models, each harboring a patient variant of unknown significance from individuals with either CHS (4) or schizophrenia (2). Next, we characterized the allelic series examining viability, behavior, and downstream gene expression.

We generated homozygous mice for each variant and examined viability. Interestingly, three lines (2 CHS and 1 schizophrenia) resulted in lethality by postnatal-day 21. Conversely, the three lines that did not alter viability showed no behavioral deficits after a complete behavior battery, suggesting they may not be pathogenic. Transcriptomic analysis of forebrain from each line compared to Cic+/+ and Cicnull/null directly correlates with survival data and allows us to quantitatively assess the severity of each variant. We are investigating if unique transcriptomic signatures exist between CHS and schizophrenia variants.

In-vivo mouse studies allowed us to confirm pathogenicity of CIC missense variants and establishing that CIC variants cause a phenotypic spectrum, ranging from childhood neurodevelopmental phenotypes to adult-onset schizophrenia.

Authors/Disclosures
Mark Durham, PhD (Baylor College of Medicine)
PRESENTER
Dr. Durham has nothing to disclose.
Jason Lucavs No disclosure on file
Alexander Trostle No disclosure on file
Hamin Lee (Baylor College of Medicine) No disclosure on file
Hu Chen (Baylor College of Medicine) No disclosure on file
Anthony Zoghbi No disclosure on file
Zhandong Liu No disclosure on file
Huda Zoghbi, MD (Baylor College of Medicine/Howard Hughes Med. Inst.) Dr. Zoghbi has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TCG. Dr. Zoghbi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cajal Neuroscience. Dr. Zoghbi has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Regeneron. The institution of Dr. Zoghbi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annual Review of Neuroscience . The institution of Dr. Zoghbi has received research support from Ionis. The institution of Dr. Zoghbi has received research support from UCB. Dr. Zoghbi has received intellectual property interests from a discovery or technology relating to health care. Dr. Zoghbi has received publishing royalties from a publication relating to health care.